MX9202670A - Derivados de 1-metilcarbapenem su preparacion y su uso como antibioticos. - Google Patents

Derivados de 1-metilcarbapenem su preparacion y su uso como antibioticos.

Info

Publication number
MX9202670A
MX9202670A MX9202670A MX9202670A MX9202670A MX 9202670 A MX9202670 A MX 9202670A MX 9202670 A MX9202670 A MX 9202670A MX 9202670 A MX9202670 A MX 9202670A MX 9202670 A MX9202670 A MX 9202670A
Authority
MX
Mexico
Prior art keywords
antibiotics
derivatives
preparation
methyl carbapenem
compounds
Prior art date
Application number
MX9202670A
Other languages
English (en)
Inventor
Isao Kawamoto
Rokuro Endo
Masao Miyauchi
Katsuhiko Watanabe
Eiji Nakayama
Hiroshi Yasuda
Satoshi Ohya
Yukio Utsui
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MX9202670A publication Critical patent/MX9202670A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
MX9202670A 1991-06-04 1992-06-04 Derivados de 1-metilcarbapenem su preparacion y su uso como antibioticos. MX9202670A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13154591 1991-06-04
JP34573791 1991-12-27
JP3052192 1992-02-18
JP9128392 1992-04-10

Publications (1)

Publication Number Publication Date
MX9202670A true MX9202670A (es) 1993-01-01

Family

ID=27459269

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202670A MX9202670A (es) 1991-06-04 1992-06-04 Derivados de 1-metilcarbapenem su preparacion y su uso como antibioticos.

Country Status (21)

Country Link
EP (1) EP0518558B1 (es)
JP (1) JP2559949B2 (es)
KR (1) KR100247855B1 (es)
CN (1) CN1030767C (es)
AT (1) ATE170521T1 (es)
AU (1) AU651887B2 (es)
CA (1) CA2070305A1 (es)
CZ (1) CZ167792A3 (es)
DE (1) DE69226815T2 (es)
DK (1) DK0518558T3 (es)
ES (1) ES2120992T3 (es)
FI (1) FI101226B1 (es)
HK (1) HK1011980A1 (es)
HU (2) HU218289B (es)
IE (1) IE921796A1 (es)
IL (1) IL102093A (es)
MX (1) MX9202670A (es)
NO (1) NO302475B1 (es)
NZ (1) NZ243022A (es)
RU (1) RU2093514C1 (es)
TW (1) TW203612B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CZ290002B6 (cs) * 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
EP0581502B1 (en) * 1992-07-21 1998-10-21 Zeneca Limited Antibiotic carbapenem compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
AU4912393A (en) * 1993-06-15 1994-12-22 Dong Kook Pharmaceutical Co., Ltd. 1-beta-methyl-2-thiolic carbapenem derivatives
JP3848693B2 (ja) * 1994-07-06 2006-11-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規カルバペネム誘導体
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
ATE223411T1 (de) * 1995-12-21 2002-09-15 Sankyo Co 1-methylcarbapenem-derivate
RU2162088C2 (ru) * 1996-04-26 2001-01-20 Санкио Компани Лимитед 1-метилкарбапенем или его фармакологически приемлемые соли, композиция, способ предупреждения или лечения бактериальных инфекций
WO1998007692A1 (en) 1996-08-17 1998-02-26 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
WO2000034282A1 (fr) * 1998-12-07 2000-06-15 Sankyo Company, Limited Derives de 1-methylcarbapenem
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
EP1430027B1 (en) 2001-09-14 2010-09-01 High Point Pharmaceuticals, LLC Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
CN101367814B (zh) * 2007-06-28 2010-12-15 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰哌啶取代的培南衍生物
US8236792B2 (en) * 2008-05-23 2012-08-07 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine H3 receptor
US11180504B2 (en) 2016-03-16 2021-11-23 Orchid Pharma Ltd. Substituted carbapenems for the treatment of bacterial infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
AU646012B2 (en) * 1990-02-23 1994-02-03 Sankyo Company Limited Carbapenem derivatives having antibiotic activity, their preparation and their use
TW198034B (es) * 1990-03-27 1993-01-11 Manyu Seiyaku Kk
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
CZ290002B6 (cs) * 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek

Also Published As

Publication number Publication date
NO302475B1 (no) 1998-03-09
KR930000515A (ko) 1993-01-15
HK1011980A1 (en) 1999-07-23
KR100247855B1 (ko) 2000-05-01
IE921796A1 (en) 1992-12-16
JPH05339269A (ja) 1993-12-21
HU211822A9 (en) 1995-12-28
DE69226815T2 (de) 1999-05-20
FI922561A0 (fi) 1992-06-03
RU2093514C1 (ru) 1997-10-20
NO922185L (no) 1992-12-07
AU651887B2 (en) 1994-08-04
ES2120992T3 (es) 1998-11-16
EP0518558B1 (en) 1998-09-02
HU218289B (en) 2000-07-28
TW203612B (es) 1993-04-11
FI101226B (fi) 1998-05-15
CN1030767C (zh) 1996-01-24
NO922185D0 (no) 1992-06-03
DK0518558T3 (da) 1999-05-31
ATE170521T1 (de) 1998-09-15
CN1069494A (zh) 1993-03-03
DE69226815D1 (de) 1998-10-08
NZ243022A (en) 1993-07-27
FI101226B1 (fi) 1998-05-15
IL102093A (en) 1996-12-05
HU9201871D0 (en) 1992-08-28
CZ167792A3 (en) 1995-12-13
FI922561A (fi) 1992-12-05
EP0518558A1 (en) 1992-12-16
CA2070305A1 (en) 1992-12-05
AU1739092A (en) 1993-03-11
IL102093A0 (en) 1993-01-14
JP2559949B2 (ja) 1996-12-04
HUT61551A (en) 1993-01-28

Similar Documents

Publication Publication Date Title
MX9202670A (es) Derivados de 1-metilcarbapenem su preparacion y su uso como antibioticos.
EP0483667A3 (en) Cyclic imino derivatives, process for their preparation and drugs containing them
DE3760532D1 (en) Benzoûb¨thiophene and benzoûb¨furancarboxamide derivatives, processes for their preparation and therapeutical agents containing them
DE3883456D1 (de) Verfahren zur Herstellung von substituierten Indolinonderivaten.
FR2593504B1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
DE3752124D1 (de) Verfahren zur Herstellung von Penem Derivaten und Zwischenprodukte zu dieser Herstellung
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
DE3673129D1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
DE3770117D1 (de) Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
DE3788369D1 (de) Verfahren zur Herstellung von Cephalosporinderivaten.
GB2001068A (en) Penicillin and cephalosporin preparation
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation